Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 84Breast Neoplasms 34Colorectal Neoplasms 26Lung Neoplasms 23Rectal Neoplasms 22Neoplasms 21Esophageal Squamous Cell Carcinoma 20Neoplasm Metastasis 19Esophageal Neoplasms 19Head and Neck Neoplasms 17Stomach Neoplasms 15Pancreatic Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Triple Negative Breast Neoplasms 12Small Cell Lung Carcinoma 12Ovarian Neoplasms 11Recurrence 10Nasopharyngeal Carcinoma 10Carcinoma, Squamous Cell 10Uterine Cervical Neoplasms 9Leukemia, Myeloid, Acute 9Colonic Neoplasms 9Glioblastoma 8Prostatic Neoplasms 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma 7Sarcoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Melanoma 6Lymphoma, Non-Hodgkin 6

Interventions

Thiotepa 2Melphalan 2Cyclophosphamide 2fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Therapeutics 1Muromonab-CD3 1Immunotherapy 1Drug Therapy 1Busulfan 1Antilymphocyte Serum 1Antibodies 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Histiocytosis × Drug Therapy × Clear all
NCT00145626 2017-06-19

HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies

St. Jude Children's Research Hospital

Phase 2 Completed
40 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡